重组人脑钠肽治疗失代偿性充血性心力衰竭的研究进展

重组人脑钠肽（rhBNP）为一种合成肽，作用与内源性脑钠肽相似，具有扩张血管、利尿、利钠、抗交感神经系统、降低醛固酮和内皮素等作用，具有降压不加快心率，不激活肾素．血管紧张素-醛固酮系统等特点。现已有许多临床实验证实其在治疗充血性心力衰竭（CHF）方面，具有有效改善心功能、减轻心脏负荷及心室重构等优势，目前rhBNP已经上市，并且已经在临床上应用于充血性心力衰竭的治疗。本文就rhBNP的药理作用，与CHF的关系，以及其治疗失代偿性CHF的进展作一综述。

Research progress on the treatment of compensatory Congestive Heart Failure with recombinant human brain natriuretic peptide

Recombinant human brain natriuretic peptide(rhBNP) is a synthetic peptide, its role is similar to endogenous brain natriuretic peptide, with effects on expanding blood vessel, diuretic, natriuretic, anti-sympathetic nervous system, decreasing plasma aldoste-rone and endothelin, also with characteristic of depress urization while neither speeding up the heart rate, nor activating the renin-angiotensin-aldosterone system. A number of studies had confirmed that recombinant human brain natriuretic peptide was effective in the treatment of Congestive Heart Failure (CHF), it could effectively improve the cardiac function, reduce the cardiac load and reverse left ventricular remodeling. It is now put on to market and applied in clinical treatment of Congestive Heart Failure. The article introduces rh-BNP pharmacologic action, the relationship with CHF, and the research progress on the treatment of CHF.